Deerfield and Roche lead $10 mln round for AveXis
Dallas-based gene therapy-focused biotech firm AveXis has raised $10 million in funding. Deerfield Management and Roche Venture Fund led the round. In addition to the funding, AveXis has added Jonathan Leff of Deerfield and Carole Nuechterlein of Roche Venture Fund to its board of directors.
9 January 2015•4 mins read
